drugset / Trial / NCT06309719
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this pilot study is to describe the early wound healing molecular events and the vascularization pattern associated with the treatment of supra-bony defects with access flap alone or in association with a combined formulation of hyaluronic acid and polydeoxyribonucleotides gel.
Timeline
- Start
- 2024-10-21
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hyaluronic Acid | Other / unclassified | — | — |
| Subject | Polydeoxyribonucleotides | Oligonucleotide (other) | — | — |